|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03759 PHARMARON
Nominal 
12.260 -0.500 (-3.918%) Ranking Overview
Ranking based on 9 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
9
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 101.33 RMB (cts) | |
| Net Profit | 1,793.35 RMB (MIL) | DPS | 20.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 1,824.00 | 103.00 | 20.95 | -- | 2,178.00 | 1,530.00 |
| 2026 | 2,153.00 | 121.50 | 24.03 | -- | 2,567.00 | 1,722.00 |
| 2027 | 2,528.50 | 142.50 | 28.60 | -- | 3,169.00 | 2,132.10 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 1,771.00 | 99.00 | 19.22 | MORGAN STANLEY | Overweight | 24.20 | 08/01/2025 | |
| 2025 | 2,149.00 | 121.00 | 30.00 | UBS | Buy | 22.60 | 26/03/2025 | |
| 2025 | 1,728.00 | 97.00 | -- | HUATAI FIN HLDGS HK | Buy | 20.79 | 27/03/2025 | |
| 2025 | 1,768.40 | 100.00 | 18.00 | GOLDMAN SACHS | Buy | 20.50 | 31/03/2025 | |
| 2025 | 2,178.00 | 122.00 | 27.00 | CICC | OutPerform | 19.50 | 02/11/2024 | |
| 2025 | 1,836.00 | 104.00 | 20.90 | BANK OF AMERICA | Buy | 19.50 | 28/03/2025 | |
| 2025 | 1,530.00 | 86.00 | 20.00 | CLSA | OutPerform | 19.10 | 30/10/2024 | |
| 2025 | 1,824.00 | 103.00 | 21.00 | CCBI | OutPerform | 19.00 | 27/03/2025 | |
| 2025 | 2,048.00 | 115.70 | 23.10 | BOCI | Buy | 18.00 | 27/03/2025 | |
| 2026 | 2,241.00 | 125.00 | 24.03 | MORGAN STANLEY | -- | -- | 08/01/2025 | |
| 2026 | 2,567.00 | 144.00 | 36.00 | UBS | -- | -- | 26/03/2025 | |
| 2026 | 2,103.00 | 118.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 27/03/2025 | |
| 2026 | 1,992.20 | 113.00 | 21.00 | GOLDMAN SACHS | -- | -- | 31/03/2025 | |
| 2026 | 2,146.00 | 121.00 | 24.40 | BANK OF AMERICA | -- | -- | 28/03/2025 | |
| 2026 | 1,722.00 | 96.00 | 20.00 | CLSA | -- | -- | 30/10/2024 | |
| 2026 | 2,160.00 | 122.00 | 24.00 | CCBI | -- | -- | 27/03/2025 | |
| 2026 | 2,537.00 | 143.40 | 28.70 | BOCI | -- | -- | 27/03/2025 | |
| 2027 | 3,169.00 | 178.00 | 45.00 | UBS | -- | -- | 26/03/2025 | |
| 2027 | 2,507.00 | 141.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 27/03/2025 | |
| 2027 | 2,132.10 | 120.00 | 23.00 | GOLDMAN SACHS | -- | -- | 31/03/2025 | |
| 2027 | 2,550.00 | 144.00 | 28.60 | BANK OF AMERICA | -- | -- | 28/03/2025 | |
| 2027 | 2,792.00 | 158.00 | 32.00 | CCBI | -- | -- | 27/03/2025 | |
| 2027 | 2,340.00 | 132.20 | 26.40 | BOCI | -- | -- | 27/03/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 16/04/2025 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,793,351 |
| %Change | 12.008% |
| EPS / (LPS) | RMB 1.013 |
| NBV Per Share (¥) | RMB 7.690 |